Astrotech Subsidiary 1ST Detect Announces Successful Pre-Clinical Trials for Mass Spectrometer Used as a Rapid Bedside Breathalyzer

By | Press Release

Astrotech (NASDAQ: ASTC) subsidiary 1st Detect, in collaboration with The University of Texas Health Science Center, now called UT Health San Antonio, announced positive preliminary results in pre-clinical trials for the BreathDetect 1000 – a rapid bedside breathalyzer for detecting bacterial infections in the respiratory tract, such as hospital-acquired pneumonia (HAP).

Read More

1ST Detect, an Astrotech Subsidiary, Strengthens IP Portfolio

By | Press Release | No Comments

1ST Detect Corporation, a subsidiary of Astrotech Corporation (NASDAQ: ASTC), announced the United States Patent and Trademark Office (USPTO) issued a key patent for increasing the performance of the company’s unique ion trap mass spectrometer used for chemical analysis and detection. 1ST Detect’s total patent count is now 17 U.S. and 6 international issued, and 7 U.S. and 10 international pending.

Read More